Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collegium Pharmaceutical Inc COLL

Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed... see more

Recent & Breaking News (NDAQ:COLL)

Collegium to Present at Upcoming Investor Conferences

GlobeNewswire April 1, 2019

Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results

GlobeNewswire February 27, 2019

Collegium to Host Conference Call to Discuss Fourth Quarter 2018 Financial Results and Provide Corporate Update

GlobeNewswire February 13, 2019

Report: Developing Opportunities within Enterprise Products Partners, Antero Midstream Partners LP, Integrated Device Technology, Collegium Pharmaceutical, GAIN Capital, and United Technologies — Future Expectations, Projections Moving into 2019

GlobeNewswire January 17, 2019

Collegium Provides Full-Year 2019 Financial Guidance

GlobeNewswire January 7, 2019

Collegium to Present at Upcoming Investor Conferences

GlobeNewswire November 12, 2018

Collegium Reports Third Quarter Financial Results

GlobeNewswire November 8, 2018

Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER

GlobeNewswire October 29, 2018

Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire October 18, 2018

Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update

GlobeNewswire October 17, 2018

Collegium to Present at Upcoming Investor Conference

GlobeNewswire September 28, 2018

Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting

GlobeNewswire September 4, 2018

Collegium Reports Second Quarter Financial Results and Provides Corporate Update

GlobeNewswire August 8, 2018

Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update

GlobeNewswire July 20, 2018

Collegium Announces Promotion of Scott Dreyer to CCO

GlobeNewswire July 10, 2018

New Research: Key Drivers of Growth for Outfront Media, Enel Chile, Banc of California, Northern Dynasty Minerals, Collegium Pharmaceutical, and Petroleo Brasileiro S.A. - Petrobras — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire June 18, 2018

Collegium Announces CEO Succession

GlobeNewswire June 4, 2018

Collegium to Present at Upcoming Investor Conferences

GlobeNewswire May 30, 2018

Collegium Reports First Quarter Financial Results and Provides Corporate Update

GlobeNewswire May 9, 2018

Collegium to Present at the Deutsche Bank Health Care Conference

GlobeNewswire May 2, 2018